MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
about
The rise of regulatory RNAControl of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAsThe Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseasesβ-Cell MicroRNAs: Small but PowerfulMicroRNAs as pharmacological targets in diabetesRole of regulatory micro RNAs in type 2 diabetes mellitus-related inflammationHypothalamic miRNAs: emerging roles in energy balance controlRisk factors and primary prevention trials for type 1 diabetesRedox homeostasis in pancreatic β cellsGender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese PigsMiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in MiceIncreased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitusmiR-24 regulates menin in the endocrine pancreasNutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source.Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction.MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.The role of microRNAs in diabetic nephropathy.MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells.Exercise: putting action into our epigenome.Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFkB activation.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milkAdaptive expression of microRNA-125a in adipose tissue in response to obesity in mice and men.Genetics of type 2 diabetes-pitfalls and possibilities.Loss of miRNAs during processing and storage of cow's (Bos taurus) milk.Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver diseaseT2DM: Why Epigenetics?Stem cell approaches for diabetes: towards beta cell replacement.Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.A simple matter of life and death-the trials of postnatal Beta-cell mass regulationThe Intestinal Transport of Bovine Milk Exosomes Is Mediated by Endocytosis in Human Colon Carcinoma Caco-2 Cells and Rat Small Intestinal IEC-6 Cells.MicroRNAs and diabetic complicationsThe Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary SyndromeAssociation study of polymorphisms in miRNAs with T2DM in Chinese population.Gene regulation by dietary microRNAs.MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRαHuman vascular endothelial cells transport foreign exosomes from cow's milk by endocytosis.Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes.miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass.
P2860
Q22121998-77D4B517-A128-4346-BB67-DF2345D68B69Q24617134-F6D041BA-7BAA-484A-A0D3-549E04057399Q26750496-3E247D36-07E5-40C4-B398-E46CCECFC24CQ26780370-5B19919F-C8EF-48EB-A54A-2ADBAC1C3DC2Q26824024-139EAED2-098C-46A5-AC14-671F750E18C7Q26830676-BA609470-5488-4F67-BECB-388D55753123Q26865728-2F1CD9F6-5F72-4588-B35C-92798E8C0A72Q27005625-7D7D0D09-E1C2-4FAC-8F64-428FB5548963Q27021930-6C3BC106-1D29-47A5-BBEA-CC767CCCCEFBQ27303508-9039850A-911D-49A9-9284-37653F2B10ECQ27307894-766F1C83-7405-40D0-909A-B29E93F0F49DQ28536498-9247F23E-BDA9-432E-B7CE-37506672E914Q28593937-0312EB31-FE2C-4F56-9581-21E8ECE56344Q30368908-DD9346A3-F5AF-479B-9884-919A3AB069C2Q33654397-F2A89F68-FBAF-4ED4-B18A-93088CC705A2Q33914260-66D84497-ED33-4ACA-BF09-A6B444E35F24Q34077389-4C49EDEE-70DD-4AD9-BB85-5AF4CD8DF1D1Q34195411-16B3A4B2-ABEC-43E5-BE57-C2F012E4E275Q34316436-F1454659-EB7C-49C2-A73B-12C35EC28981Q34380487-93C1E708-C44E-4C47-82AB-B2FEFAA3BB00Q34425141-B6333A56-2366-4901-B1C2-9CCB5C054BA3Q34426839-4737C6EC-7A75-4954-BCE8-3559E7774955Q34589459-724AA695-24F3-4E9C-B500-0769B855B95AQ35133482-56DD30DC-D3F6-4980-BFCA-407F4994E063Q35227765-B8BC8E1B-E502-4757-B1F6-4D2754F50962Q35294720-C564495D-6FB7-4024-B763-FD3528ED6CAEQ35336894-F634B8E5-2309-4D2C-8EF9-7B6516EA0D11Q35550621-5980E6FD-9853-4CDA-A4CF-17E74954626DQ35617374-84A3804A-F090-46E9-B20F-8B43449FC431Q35684542-9E79E15E-39EE-4FD7-868B-CAE96FC1CA89Q35942505-C96EFD05-D520-4B2E-80F3-CB3127278C4CQ36087851-76EB1392-33CE-495B-BB42-B82299C0B47FQ36094855-13BC1883-5366-4545-9A48-57EF28F85574Q36146144-43185C43-51F4-4C4E-ABB1-2B2C7CE17C0EQ36275002-45E38EF2-6425-4FF9-ABCB-E05A91284CD1Q36550667-7A31330E-77A0-40BD-8349-055583585FA1Q36707776-5AD5F5BB-10C2-4267-B8CA-46695888EC5CQ36975006-0E802E2D-F5D3-4CDE-A759-0F6A1CC2BD12Q36986362-83BE6921-3C36-4C75-8B5D-65C0CC53FE86Q37151171-F0256C23-811D-408B-AA87-EBDF66577B63
P2860
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@ast
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@en
type
label
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@ast
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@en
prefLabel
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@ast
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@en
P2860
P921
P356
P1433
P1476
MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications
@en
P2093
Ryan J Taft
P2860
P304
P356
10.2337/DB11-0171
P407
P5008
P577
2011-07-01T00:00:00Z